Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Cy3 TSA Fluorescence System Kit: Signal Amplification in ...

    2026-03-07

    Cy3 TSA Fluorescence System Kit: Signal Amplification in IHC & ISH

    Executive Summary: The Cy3 TSA Fluorescence System Kit (K1051) from APExBIO utilizes tyramide signal amplification (TSA) to enhance detection sensitivity for proteins and nucleic acids in fixed cells and tissues (APExBIO product page). The kit employs HRP-catalyzed deposition of Cy3-labeled tyramide, producing covalent labeling and high-density fluorescence at target sites. Cy3 fluorophore excitation (550 nm) and emission (570 nm) are compatible with standard fluorescence microscopes. This approach enables visualization of low-abundance targets, outperforming conventional immunofluorescence in sensitivity (Chen et al., 2025). The kit is validated for IHC, ICC, and ISH workflows and is intended for research use only.

    Biological Rationale

    Detection of low-abundance biomolecules is critical for understanding complex biological processes, disease mechanisms, and therapeutic targets. Conventional immunofluorescence methods often lack the sensitivity to visualize targets present at low copy numbers (related article). Tyramide signal amplification (TSA) addresses this challenge by catalytically depositing labeled tyramide molecules at the site of interest, thereby boosting signal intensity. This principle is central for studies in cancer biology, neuroscience, and inflammation, where subtle changes in protein or nucleic acid expression have major functional consequences (Chen et al., 2025).

    Mechanism of Action of Cy3 TSA Fluorescence System Kit

    The Cy3 TSA Fluorescence System Kit operates on the principle of HRP-catalyzed tyramide deposition. Upon target recognition by a primary antibody, an HRP-conjugated secondary antibody binds, localizing enzymatic activity to the target. Upon addition of Cy3-labeled tyramide and hydrogen peroxide, HRP oxidizes the tyramide, generating a highly reactive intermediate. This intermediate covalently binds to electron-rich tyrosine residues on nearby proteins (further detail). The result is a dense, localized Cy3 signal at the site of the original antigen or nucleic acid.

    • Fluorophore properties: Cy3 excitation at 550 nm; emission at 570 nm.
    • Signal amplification: Multiple Cy3 molecules deposited per target site due to catalytic turnover of HRP.
    • Covalent labeling: Signal remains after stringent washes, enabling multiplexing and robust downstream analysis.
    • Kit components: Cyanine 3 Tyramide (dry, DMSO-soluble), Amplification Diluent, Blocking Reagent.

    Evidence & Benchmarks

    • TSA-based methods detect proteins and nucleic acids at femtomole levels in fixed tissue sections (Chen et al., 2025).
    • HRP-catalyzed tyramide deposition increases signal-to-noise ratio by up to 100-fold versus standard immunofluorescence (see Table 1, DOI).
    • Cy3 TSA kits enable multiplexed detection with minimal cross-reactivity when proper blocking is used (internal benchmark).
    • Fluorescence remains stable after fixation and multiple washing steps, supporting robust imaging and co-localization (internal article).

    Applications, Limits & Misconceptions

    The Cy3 TSA Fluorescence System Kit is validated for applications in:

    • Immunohistochemistry (IHC) of paraffin-embedded and frozen tissue sections.
    • Immunocytochemistry (ICC) in cultured cell lines and primary cells.
    • In situ hybridization (ISH) for low-copy RNA or DNA targets.
    • Multiplexed detection of proteins or nucleic acids with different fluorophores.

    This article extends previous coverage (article) by detailing integration parameters and performance boundaries for the Cy3 TSA kit.

    Common Pitfalls or Misconceptions

    • TSA does not amplify signal in live cells; fixation is required for covalent deposition.
    • Signal amplification is limited by endogenous peroxidase activity; inadequate quenching can increase background.
    • Overloading with primary or secondary antibodies can cause non-specific binding and high background.
    • Cy3 fluorescence is not suitable for applications requiring UV excitation or far-red detection.
    • The kit is for research use only and is not validated for clinical diagnostics.

    Workflow Integration & Parameters

    • Store Cyanine 3 Tyramide at -20°C, protected from light, for up to 2 years.
    • Amplification Diluent and Blocking Reagent are stable at 4°C for 2 years.
    • Dissolve Cyanine 3 Tyramide in DMSO immediately prior to use to preserve activity.
    • Perform peroxidase quenching after fixation to reduce background.
    • Recommended Cy3 tyramide incubation: 10–15 minutes at room temperature (20–25°C).
    • Wash extensively post-deposition to remove unbound reagent.
    • Compatible with standard filter sets for Cy3 fluorophore (excitation 550 nm, emission 570 nm).

    For detailed protocols and troubleshooting, refer to the K1051 kit documentation.

    Conclusion & Outlook

    The Cy3 TSA Fluorescence System Kit from APExBIO provides robust, covalent signal amplification for fluorescence microscopy detection of low-abundance proteins and nucleic acids. Its utility spans IHC, ICC, and ISH, facilitating high-resolution, multiplexed analyses in basic and translational research. Ongoing studies, such as those targeting inflammasome assembly in cardiovascular disease (Chen et al., 2025), underscore the kit's impact for sensitive biomarker visualization. For advanced applications and comparative performance, see recent internal reviews (here). The kit's combination of high sensitivity, stability, and compatibility with standard laboratory workflows makes it a leading choice for research requiring ultra-sensitive detection.